We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
Cap. Flow
-$248M
Cap. Flow %
-0.63%
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148

Sector Composition

Rank Sector Weight
1 Technology 11.27%
2 Financials 10.78%
3 Industrials 9.91%
4 Healthcare 9.19%
5 Consumer Staples 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMEZ
3526
DELISTED
SPDR EURO STOXX Small Cap ETF
SMEZ
$2K ﹤0.01%
+26
New +$1.54K
ZAGG
3527
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$2K ﹤0.01%
232
AMAG
3528
DELISTED
AMAG Pharmaceuticals
AMAG
$2K ﹤0.01%
145
RST
3529
DELISTED
ROSETTA STONE INC
RST
$2K ﹤0.01%
106
HCR
3530
DELISTED
Hi-Crush Inc. Common Stock
HCR
$2K ﹤0.01%
2,815
-250
-8% -$264
PGNX
3531
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2K ﹤0.01%
300
SRF
3532
DELISTED
THE CUSHING ROYALTY & INCOME FUND
SRF
$2K ﹤0.01%
281
UNT
3533
DELISTED
UNIT Corporation
UNT
$2K ﹤0.01%
2,451
-2,335
-49% -$3.73K
DERM
3534
DELISTED
Dermira, Inc.
DERM
$2K ﹤0.01%
133
WAIR
3535
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$2K ﹤0.01%
202
ASNA
3536
DELISTED
Ascena Retail Group, Inc.
ASNA
$2K ﹤0.01%
278
+25
+10% +$205
CBPO
3537
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$2K ﹤0.01%
13
KEM
3538
DELISTED
KEMET Corporation
KEM
$2K ﹤0.01%
81
ORBC
3539
DELISTED
ORBCOMM, Inc.
ORBC
$2K ﹤0.01%
+525
New +$2.24K
AHRT
3540
AH Realty Trust
AHRT
$534M
$1K ﹤0.01%
66
ALLO icon
3541
Allogene Therapeutics
ALLO
$601M
$1K ﹤0.01%
50
ASPS icon
3542
Altisource Portfolio Solutions
ASPS
$65.4M
$1K ﹤0.01%
4
ATNI icon
3543
ATN International
ATNI
$361M
$1K ﹤0.01%
14
BATRA icon
3544
Atlanta Braves Holdings Series A
BATRA
$3.53B
$1K ﹤0.01%
40
+30
+300% +$856
BBAX icon
3545
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.56B
$1K ﹤0.01%
+14
New +$708
BBCA icon
3546
JPMorgan BetaBuilders Canada ETF
BBCA
$10.7B
$1K ﹤0.01%
15
-2,199
-99% -$111K
BBEU icon
3547
JPMorgan BetaBuilders Europe ETF
BBEU
$9.13B
$1K ﹤0.01%
15
+4
+36% +$196
BCLI
3548
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$1K ﹤0.01%
18
BHR
3549
Braemar Hotels & Resorts
BHR
$153M
$1K ﹤0.01%
115
-2
-2% -$19
BRY
3550
DELISTED
Berry Corp
BRY
$1K ﹤0.01%
+157
New +$1.47K

Similar funds

US Bancorp's Q4 2019 Portfolio in Review

As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
  • US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
  • US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
  • US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
  • US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
  • US Bancorp opened 218 new positions and closed 148 in Q4 2019.
  • US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.

Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.